-
-
-
zoey hill
Fill Finish Biopharmaceuticals market Share, Growth Analysis by 2035
Given the growing pipeline of
biologics, lack
of technical expertise, and huge capital investment in the installation of fill
/ finish equipment, a number of drug manufacturers are turning to contract
service providers in order to ensure the development of quality drug products.
This evident surge in the demand for
biologics fill and finish services has presented lucrative opportunities for
service providers having necessary fill / finish capabilities.
The financial opportunity
within the biologics fill finish services market has been
analysed across the following segments:
§ Type of Packaging Container
§ Ampoules
§ Cartridges
§ Syringes
§ Vials
§ Type of Biologic
§ Antibodies
§ Cell Therapies
§ Gene Therapies
§ Oligonucleotides
§ Proteins / Peptides
§ Vaccines
§ Others
§ Therapeutic Area
§ Oncological Disorders
§ Autoimmune Disorders
§ Infectious Diseases
§ Cardiovascular Disorders
§ Other Disorders
§ Scale of Operation
§ Preclinical / Clinical
§ Commercial
§ Company Size
§ Large
§ Mid-sized
§ Small
§ Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
§ Middle East and North Africa
Latin America
The “Biologics Fill / Finish
Services Market (3rd Edition), 2022 – 2035” report features the
following companies, which we identified to be key players in this domain:
§ AbbVie Contract Manufacturing
§ Asymchem
§ BioReliance
§ Boehringer Ingelheim BioXcellence
§ Catalent Biologics
§ Charles River Laboratories
§ Fareva
§ Fresenius Kabi
§ Glaxo SmithKline
§ Hetero Drugs
§ Intas Pharmaceuticals
§ Lonza
§ Patheon
§ Pierre Fabre
§ Recipharm
§ Samsun Biologics
§ Syngene
§ Takara Bio
§ Wacker Biotech
§ WuXi AppTec
§ WuXi Biologics
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Biologics Fill / Finish Service Providers: Market Landscape
5. Company Competitiveness Analysis
6. Biologics Fill / Finish Service Providers in North America
7. Biologics Fill / Finish Service Providers in Europe
8. Biologics Fill / Finish Service Providers in Asia-Pacific
9. Recent Partnerships
10. Recent Expansions
11. Capacity Analysis
12. Demand Analysis
13. Key Performance Indicators for Biologic Manufacturing and
Fill / Finish
14. Regional Capability Assessment
15. Biologics Fill Finish Market Sizing and Opportunity Analysis
16. Future Growth Opportunities
17. Case Study: Robotic Systems in Fill / Finish Operations
18. Case Study: Ready-To-Use Packaging Components for Aseptic
Fill / Finish
19. Concluding Remarks
20. Executive Insights
21. Appendix 1: Tabulated Data
22. Appendix 2: List of Companies and Organizations
To
view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/biologics-fill-finish-services-market/256.html
News article
women's digital health market
Learn from
experts: do you know about these
emerging industry trends?
Bioavailability
Enhancement Technologies
TIL
Therapies: A New Paradigm in Cancer Treatment
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of
Digital Transformation
About Roots Analysis
Roots
Analysis is a global leader in the pharma / biotech market research.
Having worked with over 750 clients worldwide, including Fortune 500 companies,
start-ups, academia, venture capitalists and strategic investors for more than
a decade, we offer a highly analytical / data-driven perspective to a network
of over 450,000 senior industry stakeholders looking for credible market
insights.
Learn more about Roots Analysis
consulting services:
Roots Analysis
Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
*****
#FillFinishManufacturing
#FillFinishManufacturingMarket #BiologicsFillFinish #MarketResearch
#MarketInsights
August 23, 2023
-
-
oliver lewis
Cell Therapy Manufacturing market Research Report by 2023, Forecast till 2035
Owing to the intricacies associated
with the manufacturing processes, requirement of advanced production facilities
and the growing demand for cell therapy products, developers are actively
outsourcing certain manufacturing operations and automation technologies, in
addition to expanding their in-house capabilities.
The financial opportunity associated with cell therapy manufacturing market has been
analyzed across the following segments:
§ Type
of Cell Therapy
§ T
cell therapies
§ Dendritic
cell therapies
§ NK
cell therapies
§ Stem
cell therapies
§ Source
of Cell
§ Autologous
§ Allogeneic
§
Scale of Operation
§
Clinical
§
Commercial
§ Purpose
of Manufacturing
§ In-house
Manufacturing
§ Contract
Manufacturing
§ Geographical
Regions
§ North
America
§ Europe
§ Asia
Pacific
Rest
of the World
The Cell
Therapy Manufacturing
Market (5th Edition),
2022-2035 report features the following companies, which we identified to be
key players in this domain:
§ AGC
Biologics
§ BioNTech
Innovative Manufacturing Services
§ Cell
and Gene Therapy Catapult
§ Cell
Therapies
§ Center
for Cell and Gene Therapy, Baylor College of Medicine
§ Center
for Cell Manufacturing Ireland, National University of Ireland
§ Charles
River Laboratories
§ Clinical
Cell and Vaccine Production Facility, University of Pennsylvania
§ FUJIFILM
Cellular Dynamics
§ Guy’s
and St. Thomas GMP Facility, Guy’s Hospital
§ KBI
Biopharma
§ Laboratory
for Cell and Gene Medicine, Stanford University
§ Lonza
§ MEDINET
§ Minaris
Regenerative Medicine
§ Molecular
and Cellular Therapeutics, University of Minnesota
§ Newcastle
Cellular Therapies Facility, Newcastle University
§ Nikon
CeLL innovation
§ Rayne
Cell Therapy Suite, King’s College London
§ RoslinCT
§ Scottish
National Blood Transfusion Service, Scottish Centre of Regenerative Medicine
§ Sydney
Cell and Gene Therapy
§ Thermofisher
Scientific
§ WuXi AppTec
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market
Overview
5.
Regulatory Landscape
6.
Roadmaps for Overcoming Challenges
7.
Automation Technologies for Cell Therapies Manufacturing
8.
Profiles: Industry Players
9. Profiles:
Non-Industry Players
10. Role
of Non-Profit Organizations
11.
Clinical Trial Analysis
12.
Partnerships and Collaborations
13. Recent
Expansions
14. Big
Pharma Initiatives
15.
Capacity Analysis
16. Demand
Analysis
17. Cost
Price Analysis
18. Make
Versus Buy Decision Making Framework
19. Total
Cost of Ownership
20. Market
Sizing and Opportunity Analysis
21. Key
Insights
22. SWOT
Analysis
23.
Concluding Remarks
24. Survey
Analysis
25.
Interview Transcripts
26. Appendix
1: Tabulated Data
27.
Appendix 2: List of Companies and Organizations
To
view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html
Learn
from experts: do you know about these
emerging industry trends?
Deep
Learning-based Interoperability: Advanced Neural Networks Mimicking the Human
Brain
Novel Cell Cytometers:
Need of the Hour
Learn from our recently published
whitepaper: -
Next
Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the
pharma / biotech market research. Having worked with over 750 clients
worldwide, including Fortune 500 companies, start-ups, academia, venture
capitalists and strategic investors for more than a decade, we offer a highly
analytical / data-driven perspective to a network of over 450,000 senior
industry stakeholders looking for credible market insights.
Learn more about Roots
Analysis consulting services:
Roots Analysis Consulting - the
preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
*****
July 12, 2023
-
-
-
-
-
Share
